Yanru Qin

1.7k total citations · 1 hit paper
52 papers, 797 citations indexed

About

Yanru Qin is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yanru Qin has authored 52 papers receiving a total of 797 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 19 papers in Molecular Biology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yanru Qin's work include Gastric Cancer Management and Outcomes (8 papers), Cancer Cells and Metastasis (5 papers) and Nanoparticle-Based Drug Delivery (5 papers). Yanru Qin is often cited by papers focused on Gastric Cancer Management and Outcomes (8 papers), Cancer Cells and Metastasis (5 papers) and Nanoparticle-Based Drug Delivery (5 papers). Yanru Qin collaborates with scholars based in China, United States and Hong Kong. Yanru Qin's co-authors include Zehua Wang, Chen Chen, Yi Ding, Xiaohong Chen, Chunyan Chen, Changqun Cai, Guanqun Zhong, Yongqiang Zhu, Chunfeng Hu and Meng Lei and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Yanru Qin

47 papers receiving 786 citations

Hit Papers

Tumor microenvironment-me... 2023 2026 2024 2023 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma
    2023 171 citations Chen Chen, Zehua Wang et al. Frontiers in Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanru Qin China 15 278 198 133 117 115 52 797
György Trencsényi Hungary 17 279 1.0× 238 1.2× 113 0.8× 187 1.6× 140 1.2× 96 1.1k
Yulian Wu China 19 410 1.5× 173 0.9× 158 1.2× 186 1.6× 120 1.0× 42 843
Liqin Yuan China 15 279 1.0× 175 0.9× 162 1.2× 108 0.9× 94 0.8× 29 676
Yawen Guo China 18 326 1.2× 179 0.9× 126 0.9× 99 0.8× 142 1.2× 51 1.0k
Yaodong Chen China 16 356 1.3× 113 0.6× 131 1.0× 130 1.1× 184 1.6× 35 715
Patricia Juárez Mexico 13 298 1.1× 251 1.3× 99 0.7× 88 0.8× 111 1.0× 26 718
Zeinab Zarei‐Behjani Iran 11 367 1.3× 197 1.0× 206 1.5× 52 0.4× 136 1.2× 33 962
Jungshan Chang Taiwan 19 386 1.4× 223 1.1× 111 0.8× 138 1.2× 200 1.7× 50 909

Countries citing papers authored by Yanru Qin

Since Specialization
Citations

This map shows the geographic impact of Yanru Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanru Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanru Qin more than expected).

Fields of papers citing papers by Yanru Qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanru Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanru Qin. The network helps show where Yanru Qin may publish in the future.

Co-authorship network of co-authors of Yanru Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Yanru Qin. A scholar is included among the top collaborators of Yanru Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanru Qin. Yanru Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sui, Xin, Yongxu Jia, Jing Li, et al.. (2025). Identification of CTSC-driven progression in ESCC by single-cell sequencing and experimental validation. Frontiers in Immunology. 16. 1585139–1585139.
2.
Yang, Chan, Zihan Yan, Yanru Qin, et al.. (2025). Strategic design of self-disassembling Co-PDI fluorescent architecture for dual detection of ascorbic acid and alkaline phosphatase in biological systems. Sensors and Actuators B Chemical. 442. 138141–138141.
3.
Yu, Xianjun, Jieer Ying, Enxiao Li, et al.. (2025). Claudin18.2 (CLDN18.2) expression and efficacy in pancreatic ductal adenocarcinoma (PDAC): Results from a phase I dose expansion cohort evaluating IBI343.. Journal of Clinical Oncology. 43(16_suppl). 4017–4017. 2 indexed citations
4.
Wang, Lei, et al.. (2024). Crosstalk between the nervous system and tumor microenvironment: Functional aspects and potential therapeutic strategies. Cancer Letters. 594. 216986–216986. 24 indexed citations
5.
Liu, Wenjing, Lin Wang, Feng-Mei Zhou, et al.. (2024). Hexavalent chromium induced metabolic reprogramming, carcinogenesis and tumor progression through PDK1 upregulation. Ecotoxicology and Environmental Safety. 288. 117341–117341.
6.
Qin, Yanru, Shupeng Wang, Yong Fan, et al.. (2024). Osthole-infused polyurethane flexible coatings for enhanced underwater drag reduction and robust anti-biofouling. Progress in Organic Coatings. 188. 108213–108213. 17 indexed citations
7.
Qin, Yanru, Jingjing Xue, Shupeng Wang, et al.. (2023). Capsaicin-based silicone antifouling coating with enhanced interlocking adhesion via SIPN. Colloids and Surfaces A Physicochemical and Engineering Aspects. 677. 132346–132346. 13 indexed citations
8.
Ding, Yi, et al.. (2023). The gene regulatory molecule GLIS3 in gastric cancer as a prognostic marker and be involved in the immune infiltration mechanism. Frontiers in Oncology. 13. 1091733–1091733. 1 indexed citations
9.
Wang, Zhongjie, Yanru Qin, Xueyuan Wang, et al.. (2023). Glutathione Programmed Mitochondria Targeted Delivery of Lonidamine for Effective Against Triple Negative Breast Cancer. International Journal of Nanomedicine. Volume 18. 4023–4042. 8 indexed citations
10.
Shi, Litong, Zehua Wang, Lei Wang, et al.. (2022). A Prognostic Nomogram and Heat Map to Predict Survival in Stage II/III Gastric Cancer Patients After Curative Gastrectomy Followed by Adjuvant Chemotherapy. SHILAP Revista de lepidopterología. 6 indexed citations
11.
Dong, Ningning, Wenjia Wang, Yanru Qin, Yang Wang, & Hongbo Shan. (2022). Sensitive lateral flow assay for bisulfite-free DNA methylation detection based on the restriction endonuclease GlaI and rolling circle amplification. Analytica Chimica Acta. 1227. 340307–340307. 16 indexed citations
12.
Wang, Lei, et al.. (2022). Overcoming the therapeutic resistance of hepatomas by targeting the tumor microenvironment. Frontiers in Oncology. 12. 988956–988956. 8 indexed citations
13.
Wang, Xueyuan, Lin Yang, Zhongjie Wang, et al.. (2022). Co-delivery of immunochemotherapeutic by classified targeting based on chitosan and cyclodextrin derivatives. International Journal of Biological Macromolecules. 226. 1396–1410. 8 indexed citations
14.
Wang, Zehua, Chen Chen, Lei Wang, Yongxu Jia, & Yanru Qin. (2022). Chimeric antigen receptor T-cell therapy for multiple myeloma. Frontiers in Immunology. 13. 1050522–1050522. 11 indexed citations
15.
Cheng, Yuan, Shukui Qin, Jin Li, et al.. (2021). A multicenter clinical study: personalized medication for advanced gastrointestinal carcinomas with the guidance of patient-derived tumor xenograft (PDTX). Journal of Cancer Research and Clinical Oncology. 148(3). 673–684. 5 indexed citations
16.
17.
Qin, Yanru, Aimin Zang, Lijuan Yang, et al.. (2021). 840P Preliminary phase I/II study results of orelabrutinib combined with MIL62 in patients with relapsed or refractory B-cell non-Hodgkin lymphoma. Annals of Oncology. 32. S778–S778. 2 indexed citations
18.
Gao, Yaping, et al.. (2019). <p>Prognostic implications of MYBL2 in resected Chinese gastric adenocarcinoma patients</p>. OncoTargets and Therapy. Volume 12. 1129–1135. 11 indexed citations
19.
Zhou, Hui, Yanru Qin, Zhaogang Liu, et al.. (2018). Discovery of a new class of valosine containing protein (VCP/P97) inhibitors for the treatment of non-small cell lung cancer. Bioorganic & Medicinal Chemistry. 27(3). 533–544. 13 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by György Trencsényi Breakdown of academic impact, for papers by Yulian Wu Breakdown of academic impact, for papers by Liqin Yuan Breakdown of academic impact, for papers by Yawen Guo Breakdown of academic impact, for papers by Yaodong Chen Breakdown of academic impact, for papers by Patricia Juárez Breakdown of academic impact, for papers by Zeinab Zarei‐Behjani Breakdown of academic impact, for papers by Jungshan Chang
Rankless by CCL
2026